Search research articles
Contact Us
Filters
Showing results (991-1000 of 1,035) with videos related to
Page
of 104
Sort By:
Journal of Medical Genetics
|
February 18, 2011
Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK
Anne E Cust, Mark Harland, Enes Makalic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2020
Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma
Amit M Oza, Domenica Lorusso, Carol Aghajanian, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2012
Ovarian cancer, version 3.2012
Robert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.
Gynecologic Oncology
|
March 17, 2019
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia
Louiza S Velentzis, Megan A Smith, Kate T Simms, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 22, 2013
Ovarian cancer, version 2.2013
Robert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2019
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer
Amit M Oza, Ursula A Matulonis, Angeles Alvarez Secord, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 28, 2025
Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial
Jonathan A Ledermann, Amit M Oza, Domenica Lorusso, et al.
Cancer Epidemiology
|
February 14, 2013
The Childhood Leukemia International Consortium
Catherine Metayer, Elizabeth Milne, Jacqueline Clavel, et al.
Occupational and Environmental Medicine
|
May 26, 2009
Determinants of mobile phone output power in a multinational study: implications for exposure assessment
M Vrijheid, S Mann, P Vecchia, et al.
Cancer Research
|
December 25, 2016
MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2
Rajdeep Das, Philip A Gregory, Rayzel C Fernandes, et al.
Page
of 104
Search research articles
Search
Showing results (991-1000 of 1,035) with videos related to
Sort By:
Page
of 104
Journal of Medical Genetics
|
February 18, 2011
Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK
Anne E Cust, Mark Harland, Enes Makalic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2020
Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma
Amit M Oza, Domenica Lorusso, Carol Aghajanian, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2012
Ovarian cancer, version 3.2012
Robert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.
Gynecologic Oncology
|
March 17, 2019
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia
Louiza S Velentzis, Megan A Smith, Kate T Simms, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 22, 2013
Ovarian cancer, version 2.2013
Robert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2019
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer
Amit M Oza, Ursula A Matulonis, Angeles Alvarez Secord, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 28, 2025
Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial
Jonathan A Ledermann, Amit M Oza, Domenica Lorusso, et al.
Cancer Epidemiology
|
February 14, 2013
The Childhood Leukemia International Consortium
Catherine Metayer, Elizabeth Milne, Jacqueline Clavel, et al.
Occupational and Environmental Medicine
|
May 26, 2009
Determinants of mobile phone output power in a multinational study: implications for exposure assessment
M Vrijheid, S Mann, P Vecchia, et al.
Cancer Research
|
December 25, 2016
MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2
Rajdeep Das, Philip A Gregory, Rayzel C Fernandes, et al.
Page
of 104